Ashish M. Kamat, MD, MBBS
@UroDocAsh
Followers
10,642
Following
766
Media
904
Statuses
8,714
Endowed Professor, Surgeon, Former Fellowship Director @MDAndersonNews | President, IBCG | Assoc Editor @EurUrolOncol | Views my own
Houston, TX
Joined March 2010
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Oasis
• 579387 Tweets
Switch
• 284841 Tweets
Shadow
• 207685 Tweets
#SonicMovie3
• 172467 Tweets
ニンダイ
• 131029 Tweets
#GMMTVLiveHouse
• 74725 Tweets
#西園寺さんは家事をしない
• 61195 Tweets
Mikel Merino
• 47433 Tweets
Sancho
• 44726 Tweets
アトリエ
• 40270 Tweets
Sterling
• 38541 Tweets
グレイセス
• 38153 Tweets
Toney
• 33723 Tweets
テイルズ
• 28174 Tweets
ときメモ
• 24272 Tweets
ときメモ
• 24272 Tweets
#NintendoDirect
• 23245 Tweets
幻想水滸伝
• 18121 Tweets
Pizza Tower
• 15010 Tweets
ピザタワー
• 14655 Tweets
軌跡シリーズ
• 11971 Tweets
コーヒートーク
• 11967 Tweets
ルンファク
• 11478 Tweets
Keith Lee
• 10218 Tweets
Pinned Tweet
It’s here!
#BladderCancer
: a practical guide.
🌟 authors:
@bbmdmsk
@JoshMeeks
@DrShariat
@ahmostafid
@MattGalsky
@ArjunBalarMD
@MRoupret
@SpiessPhilippe
@OncoBellmunt
@Prof_Nick_James
@BrantInman
@PGrivasMDPhD
@drphil_urology
@AlisonBirtle
30
66
445
In well selected patients - solitary tumors < 7 cm, no or unilateral hydronephrosis, minimal CIS - results with TMT are comparable to Radical Cystectomy
#patientchoice
#bladdercancer
#BladderCancerMonth23
@TheLancetOncol
@BladderCancerUS
7
163
410
The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC)
Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place
#AUA24
#EAU24
#IBCG24
#ASCO24
Designed by
@AmandaMyersMD
12
158
353
BCG cheat sheet
@BladderCancerUS
for patients
- includes schedule for patients to use/bring to their urologist's clinics for scheduling
#bladdercancer
#patientsafety
#immunotherapy
@bcan_chisolm
@MDAndersonNews
@EurUrolOncol
@urotoday
@JanetKukreja
8
49
246
Our collaborative review on LND in GU cancers; tremendous effort by
@AmandaMyersMD
@MDAndersonNews
#OncSurgery
@EurUrolOncol
Open Access link:
@Albert0Briganti
@BradLeibovichMD
#SethLerner
@UroMoschini
@MRoupret
@DrShariat
@SpiessPhilippe
@Astenzl
5
99
245
As I turn 50 today, I ponder the things in life I am grateful for
Clearly family, friends, and the love I receive have always been at the top of my list
But in these times, reminded how fragile life is, I can say that those are the *only* things that matter to me anymore.
74
6
223
Just released! Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer (SITC) and the International Bladder Cancer Group (IBCG)
@JCO_ASCO
@IBCG_BladderCA
@sitcancer
8
95
214
I’m getting lots of queries about whether we’re overreacting to
#COVID19
.
When all is said and done:
It will be impossible to know if we overreacted. But it will be painfully obvious if we underreacted and did too little, especially to those who lost loved ones
#Flattenthecurve
8
38
203
The
@Uroweb
EAU Guidelines in
#BladderCancer
are probably the most followed guidelines globally in
#OncSurgery
We are thankful for the invitation to present our 'challenges' to these guidelines - mainly our suggestions for improving what are already excellent guidelines by the
2
51
192
27 years strong! Grateful for my rock, my best friend, and the light in my world. Here's to many more years of love, laughter, and memories. Love you now and always! 💕
#HappyAnniversary
19
0
180
Impact Factors for 2023 are out!
Top Ten for
#urology
collated by
@KariTikkinen
Congratulations to
@EUplatinum
@EurUrolOncol
@NatRevUrol
@EurUrolFocus
@JUrology
@BJUIjournal
7
47
173
Impressive results with IL-15 Superagonist in BCG-Unresponsive NMIBC
@NEJM
#SIU2022
@UroCancerMD
@DrPatSoonShiong
@Agarwal_CaB
@KhurshidGuru
7
75
171
@JoaquinCastrotx
Thank you for sharing and for your efforts supportive of fighting cancer
@MDAndersonNews
#EndCancer
Wishing you the best of health
@JoaquinCastrotx
0
7
156
@MeetThePress
"We're being investigated?
Here's some money
Oh, its a 100 countries behind the petition?
Here's lots of money"
Sound familiar?
9
6
119
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
0
55
140
A well designed study shows equivalence of robot with open cystectomy. Notably ~67% adverse events in both groups. Emphasizing that this is a complex surgery; the ‘tool’ ie scalpel or robot less important than skill of surgeon and overall expertise of the team
@B_C_A_N
Robot-assisted radical
#cystectomy
versus open radical cystectomy in patients with
#bladdercancer
(RAZOR): an open-label, randomised, phase 3, non-inferiority trial
2
91
81
8
73
138
Let the debates start (again!)
PHOTO: Randomized trial
PDD-guided TURBT did not reduce recurrence rates, nor was it cost-effective compared with WL at 3 years
@NEJMEvidence
@ParamMariappan
@EmmaHall71
@BAUSurology
@siadaneshmand
#bladdercancer
14
54
136
The Who, What, When, Where, and Why of BCG-unresponsive Bladder Cancer
@UrogerliMD
@EurUrolOncol
3
31
135
Just released …
Our inaugural impact factor for
@EurUrolOncol
is … 7.479
Congratulations to all our readers, authors, contributors and everyone on the EU family of journals board!
Alberto Briganti
@GGiannarini
@AlbigesL
@DrPaulNguyen
9
23
136
Congratulations to the entire team on approval of Nadoferagene for BCG unresponsive NMIBC
@ferring
@MDAndersonNews
@UroOnc
#bladdercancer
6
48
129
Many colleagues were not able to get into full room for
#EAU19
#EAUGuidelines
controversies and enjoy debates by
@MarekBabjuk
@JimCatto
@paolo_gontero
@NDowJames
Max Berger
@Uroweb
on reTUR in NMIBC. Here are my slides:
11
47
127
Current best practice for
#bladdercancer
: a narrative review of diagnostics and treatments
@TheLancet
@evacomperat
@achoud72
@MahulAminMD
@AStenzl
@ThoenyHarriet
@MDAndersonNews
0
46
124
Our
@MDAndersonNews
analysis showing all TaHG tumors behave similar and should be classified as High Risk
will form the basis for
#clinicaltrial
guidance
@FDAOncology
@IBCG_BladderCA
@sitcancer
@KKBree
@pjhensley11
@niyatilobo
#OncSurgery
@JUrology
3
45
126
Outstanding Systematic Review of Risk Factors and Epidemiology of
#BladderCancer
in 2023 by
@IJubber
@_SeanOng
@marcuskwesi
@JimCatto
@LauraBukavinaMD
@pcvblack
@evacomperat
@JoshMeeks
@AndreaNecchi
@VPanebiancoIT
@kalasri3
@EUplatinum
2
34
125
A Happy Diwali from our family to yours. 🪔 💥 🪔
May the triumph of light over darkness, good over evil, love over hate
Bring you an abundance of happiness, joy, peace and health
Now, and always
#Diwali2022
15
3
120
Importance of repeated stimulation of immune system with maintenance BCG has been known; forgotten; restudied; known again; forgotten; restudied again ... enough times that if someone says to you “I don’t believe in maintenance BCG” just show them the door out
#GU20
#GU2020
Wow. Explain to me why we shouldn’t do maintenance BCG. Well done trial showing reduced dosing clearly inferior to standard
3
13
46
3
39
118
Plasmacytoid variant of
#BladderCancer
: a deadly disease.
Positive margin rates are 800% times that seen with conventional urothelial cancer and highly associated with mortality.
@JUrology
13
38
117
After overcoming
#coronavirus
(COVID-19), George Chang, a colleague, friend and outstanding surgeon donates plasma to help others
@MDAndersonNews
@PPisters
2
17
117
Just received this out-of-office message. Love it!
Next step: summon the courage to adopt it for myself and try it out on
#OncSurgery
colleagues
@MDAndersonNews
#Wellness
#MedTwitter
9
10
118
Countdown to
#AUA24
; looking forward to the
AUA-IBCG Bladder Cancer Forum
Sunday, May 5, 2 - 5 pm
@AmerUrological
@IBCG_BladderCA
@JanetKukreja
@AmandaMyersMD
@BladderCancerUS
@AndreaNecchi
@PGrivasMDPhD
@UrogerliMD
@karima_oualla
@shilpaonc
@SWilliams_MD
@ParamMariappan
7
32
117
Our historic
@MDAndersonNews
experience with preoperative radiotherapy + radical cystectomy for
#bladdercancer
: significant impact on local control for T3b disease
Glad to see it being studied along with IO in RACE-IT and RAD- VACCINE
2
32
116
Congratulations to my mentor and friend
@CurtisPettaway1
for being awarded the Huggins Medal by the Society of Urologic Oncology
To be presented at the
#SUO21
meeting
#OncSurgery
@MDAndersonNews
@UroOnc
9
8
114
Hyperthermic chemo does not improve DFS in intermediate risk NMIBC: DFS @ 24 mos: 61% vs 60%
Conclusive results from HIVEC-II RCT : led by
@drtanws
while at
@UCLH
- now
@UroOnc
@MDAndersonNews
@ahmostafid
@Issarami
@QMBCI
@EUplatinum
#bladdercancer
1
39
111
Definition of progression in NMIBC trials should include/report
development of MIBC or greater (N+ or M+)
an increase in T stage from CIS or Ta to T1
an increase in grade from low to high
@IBCG_BladderCA
@JUrology
@joanfundi
@pjhensley11
@evacomperat
6
31
104
As of today, FDA approved
#pembrolizumab
for the treatment of BCG unresponsive, high-risk NMIBC for patients who are not eligible for or opt against undergoing cystectomy
@BladderCancerUS
After thoughtful deliberations by the panel; a positive vote towards helping our patients with BCG Unresponsive
#BladderCancer
have more options - in this case Pembrolizumab - to chose from.
@ArjunBalarMD
@garysteinbergmd
@BladderCancerUS
9
19
58
5
38
101
Chemoradiotherapy in MIBC: 10-yr follow-up of the Phase 3 RCT BC2001 : addition of chemotherapy improved 5-yr locoregional RFS 63% vs 49% and salvage cystectomy rate from 14% vs 22%
@EmmaHall71
@Prof_Nick_James
@EUplatinum
@achoud72
3
34
103
Real-world data: 287 pts cN+ M0
#BladderCancer
Median OS < 2 years; ~ 20% 5 yr survival
Similar results in the RC or RT cohorts (including when restricting the analysis to patients who received NAC)
Patients treated with radical intent had better outcomes - median survival:
2
38
101
A touching token of appreciation from a patient (deemed incurable at several other centers 5 yrs ago). He is a surgeon himself and created this himself with the Sanskrit 'Vande Gurunam' inscribed in my initials. This is what makes it all worthwhile.
@MDAndersonNews
13
7
100
Join us at
#AUA23
for our
2nd AUA-IBCG
#BladderCancer
Forum
Sun, April 30th 2 - 5 pm
@UrogerliMD
@paolo_gontero
@garysteinbergmd
@SWilliams_MD
@uromc
@tbivala1
@spsutkaMD
@SimaPorten
@bbmdmsk
@AStenzl
@JoshMeeks
@WesKassouf
@PGrivasMDPhD
@nnavai
@MaxKates
@shilpaonc
@MariaJRibal
5
34
100
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
5
28
99
Intermediate-risk NMIBC: Updated Consensus Definition & Management Recs from IBCG (International Bladder Cancer Group)
Full text:
@drtanws
@garysteinbergmd
@DrShariat
@UrogerliMD
@MRoupret
@spsutkaMD
@joanfundi
@MarekBabjuk
@SWilliams_MD
#bladdercancer
3
32
97
Join us April 5th for the 7th edition of
Rapid Fire Debates in
#BladderCancer
#EAU2024
#EAU24
@MRoupret
@spsutkaMD
@AndreaNecchi
@joanfundi
@evacomperat
@SpiessPhilippe
@BenjaminPradere
@JBjerggaard
@AlisonBirtle
@MarekBabjuk
@paolo_gontero
@JimCatto
@pcvblack
@AStenzl
@Uroweb
2
29
96
Meta-analysis of
#ERAS
protocols in
#bladdercancer
confirms reduced LOS and postoperative complication after radical cystectomy; association with no NG tubes and local anesthetic blocks
@EUplatinum
@EurUrolOncol
1
35
95
Congratulations
@KKBree
@MDAndersonNews
for being awarded the
"Most Impactful Article of 2022" by the flagship journal of our society
@AmerUrological
@JUrology
#OncSurgery
and which has formed the basis for
#clinicaltrial
guidance
@FDAOncology
@IBCG_BladderCA
@SWOG
Our
@MDAndersonNews
analysis showing all TaHG tumors behave similar and should be classified as High Risk
will form the basis for
#clinicaltrial
guidance
@FDAOncology
@IBCG_BladderCA
@sitcancer
@KKBree
@pjhensley11
@niyatilobo
#OncSurgery
@JUrology
3
45
126
10
18
95
First targeted therapy approved for bladder cancer ever
FDA approves first targeted therapy for metastatic bladder cancer:
#erdafitinib
#bladdercancer
2
78
138
3
23
91
Thrilled that active surveillance for
#BladderCancer
has made it into
#EAU23
Guidelines
@Uroweb
@paolo_gontero
@MRoupret
Watch out for data from
@drtanws
@IBCG_BladderCA
@RobertoContieri
@ValGraj
@MDAndersonNews
on this topic
@SUO_YUO
@AmerUrological
@BladderCancerUS
@UroOnc
6
34
99
Double the celebration, double the fun!
Thrilled to witness Anant and Radhika's beautiful union and enjoy the incredible match at Wimbledon Finals.
Cheers to the happy couple, and congrats to the Wimbledon champs!
#AnantRadhikaWedding
#Wimbledon2024
3
1
91
8
7
88
The entire landscape of
#BladderCancer
#DrugDevelopment
on one slide; courtesy Noah Hahn
@JohnsHopkins
@Brady_Urology
@BladderCancerUS
"Mapping Progress in Bladder Cancer" This rapidly evolving landscape is incredibly exciting.
@UroDocAsh
@MDAndersonNews
expands on the progress in bladder cancer & an explosion of clinical trials expanding our options. Full article by
on UroToday now.
1
39
49
4
43
89
Radical cystectomy associated with improved survival rates and lower costs compared to radiation therapy for
#BladderCancer
@SWilliams_MD
@B_C_A_N
@JAMASurgery
@MDAndersonNews
@utmbhealth
5
63
88
Thanks to all who have contributed to
@EurUrolOncol
and helped make it such a high impact publication already. Keep ‘em coming!
2
16
87
Confirmed! Men and women *are* different; even at the molecular level of
#bladdercancer
they develop: basal/squamous subtypes higher in females; luminal papillary (LumP) & neuroendocrine-like higher in males
@EurUrolOncol
@SimaPorten
@JoepJdeJong
0
31
88
“Become friends with your medical oncologist” - Fred Witjes
#EAU22
#bladdercancer
@MRoupret
@MariaJRibal
6
19
87
A 2nd induction course of BCG improves CR rates from 78.2% to 89.7%. Durable responses seen - @ 36 mos CR 65.6%
#bladdercancer
@MaxKates
@tbivala1
@joanfundi
@MarekBabjuk
@SUO_YUO
2
30
86
Contemporary Outcomes of NMIBC Patients Treated with BCG
@MDAndersonNews
Lower rates of progression/recurrence than often cited historical series- implications for clinical trial design
@UrogerliMD
@nnavai
@VikramNarayan
@IBCN1997
@IBCG_BladderCA
5
33
86
We are excited to announce the formation of the IBCG-GSRGT Joint Committee on Rare Variants of
#BladderCancer
@PhilippSpiess
@IBCG_BladderCA
@AndreaNecchi
@GTumors
@shilpaonc
@UrogerliMD
🧵 1/5
4
17
85
Adherence to NMIBC guidelines ~71%.
Over treatment of low-risk disease
Overuse of UT imaging, frequent cystoscopy, & cytology.
Full text link, courtesy
@SUO_YUO
@UrolOncol
@UroOnc
2
34
84
From our family to yours, near and far, on the occasion of
#Diwali2021
: here’s hoping your future is full of happiness, gratitude, love, positivity, and the
#FestivalOfLights
brings you and your loved ones peace and joy, always 🪔
7
8
82
A Herculean effort with practice changing implications!
LNDs for
#bladdercancer
will not be the same after Monday June 5
#ASCO23
(except by those who continue to disbelieve RCTs!)
@SWOG
Great to see S1011 abstract for
@ASCO
. Congrats to S1011 team.
@slernerbcmedu1
@siadaneshmand
@SvatekRob
@ecskinner53
@UroDocAsh
@WesKassouf
@AnneSchuckmanMD
@montypal
@SWOG
@SupportingSWOG
7
23
97
4
21
83
Further evidence that Gem/Doce is reasonable alternative to BCG in patients with high-risk NMIBC, during the ongoing BCG shortage
@IanMcelree
@VigneshPackiam
@ryansteinbergmd
@uiowa
@JAMANetworkOpen
@JAMANetwork
#Bridge
Trial
@MaxKates
@angiesmith_uro
2
30
83
Hematuria nomogram incorporating ultrasound reduces the need for cystoscopy by 30%
@drtanws
@MDAndersonNews
#AUA23
5
25
80
Clinical Validation of the Intermediate-risk NMIBC Scoring System and Substratification Model Proposed by the IBCG (International Bladder Cancer Group): A Multicenter YAU Urothelial Working Group Collaboration
@EurUrolOncol
@paolo_gontero
@frasor86
a🧵
4
31
81
Elegant work suggesting that metastases driven mutations are associated with drug resistance rather than tumorigenesis
@StanfordMed
Rationale to support maintenance therapy
@MattGalsky
@tompowles1
@Aiims1742
@montypal
@VivekSubbiah
@PGrivasMDPhD
#ASCO2020
6
17
80
0
63
80
Join us at
#EAU23
for our Rapid Fire Debate
#BladderCancer
Session
Sat, March 11, 3:15 pm
@MarekBabjuk
@joanfundi
@paolo_gontero
@slernerbcmedu1
@UrogerliMD
@MRoupret
@LAUrology_NL
@ParamMariappan
@JBjerggaard
@JimCatto
@amassonlecomte
@DrShariat
@AndreaNecchi
@AStenzl
@Uroweb
3
22
78
Cancer patients have higher incidence of
#COVID19
infection. Aggressive measures needed to protect/reduce frequency of hospital visits
@MDAndersonNews
@VivekSubbiah
@Aiims1742
@tmprowell
5
36
73
Here it is!
A consensus molecular classification of muscle-invasive
#BladderCancer
@EUplatinum
2
26
76
Thrilled to announce the IBCG Bladder Cancer Forum at
#AUA22
with an exciting program lined up for you thanks to
@IBCG_BladderCA
@DrJohnDenstedt
@SimaPorten
@pjhensley11
Case based debates;
State of the art lectures:
@AStenzl
@MattGalsky
S. Lerner
Sunday, May 15th 2 - 5 pm
2
22
77
Divergent effect of diet on the immune system
Ketogenic diet enriching for adaptive immune signatures (beneficial in cancer)
Vegan diet -> for innate immune signatures
@Nature
3
27
78
SEER data showing decreasing death rates from several GU cancers
For
#bladdercancer
- both death rates and incidence decreased
H/T
@tmprowell
#EAU21
3
25
77
Elegant work showing limitations of clinical (re)staging after NAC to justify avoiding radical cystectomy.
@tbivala1
@MaxKates
@djmcconkey
@GottfridSjodahl
@pcvblack
7
34
77
Post cystectomy, ctDNA analysis identified all patients with metastatic
#BladderCancer
relapse during monitoring (100% sensitivity, 98% specificity) with a median lead time of 3+ months over imaging. Implications for adjuvant trial designs
@LDyrskjot
Cell-free DNA analysis for monitoring relapse and treatment efficacy in urothelial bladder cancer, by
@LDyrskjot
@AarhusUni
& colleagues
#blcsm
0
17
28
1
30
75
Just dropped my first born off to college this weekend. Was much harder than I thought it would be.
#heldbackthetears
#dadsdontcry
6
0
76
NOT ready for prime time
@pcvblack
discusses his insights re: molecular classification of
#bladdercancer
in a rational manner, devoid of hype and/or hyperbole!
#EAU22
@MRoupret
@MariaJRibal
@djmcconkey
@GottfridSjodahl
@LDyrskjot
5
25
75
The kindness of humanity is humbling.
My 84 yr old patient whom I called to inform that we were postponing his surveillance visit due to
#COVID19
said “yes doc, totally understand”
... then showed up later to drop off food for my clinic ... and left so as to not disturb me!
GOLDEN MOMENTS IN TELEHEALTH
“Doctor Lewis, I am grateful for the call but sorry we couldn’t have an in-person visit”
“Why is that, ma’am?”
“Because I wanted to bring food for you and your family in case you were running low”
☝️this is what will get us through.
#medtwitter
8
22
474
2
3
75
Thrilled to be welcoming a dear friend and colleague
@SiaDaneshmand
as Visiting Professor
@MDAndersonNews
Exciting all day program with our
@SUO_YUO
fellows organized by
@ChapinMD
#OncSurgery
2
10
73
Great news for our
#bladdercancer
patients!
On December 15, 2023, the Food and Drug Administration (FDA) approved enfortumab vedotin-ejfv (Padcev, Astellas Pharma) in combination with pembrolizumab (Keytruda, Merck) for patients with locally advanced or metastatic urothelial
1
27
74
Dropped our youngest off to college today
People say “you’ll get used to it”
Nope.
4
2
73
2021 EAU Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with NMI Bladder Cancer Treated with BCG
#OncSurgery
@EurUrolOncol
@niyatilobo
@MDAndersonNews
#BlackBerry
12
23
73
En bloc TURBT (for <1 cm tumors) results in
Similar recurrence rates: 18.4% vs 16.7% at 1 yr
Similar residual disease on reTUR 56% vs 55.9% (small subset)
More retrieval of DM: 80.7% vs 71.1%
Less bladder perforation: 5.6% vs 12%
Similar OR time: 26 vs 25 min
Highlight: En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial
#UroSoMe
#Medtwitter
3
25
52
3
30
72
A country of 1.2 billion people goes on complete lockdown for 21 days
This despite having only 536 cases and 10 deaths from
#COVID19
This is how one deals with a pandemic!
@narendramodi
@realDonaldTrump
4
12
71
@JUrology
Progression free survival at 5 yrs > 90% for high risk NMIBC patients with appropriate use of BCG immunotherapy
#BladderCancer
#ASCO21
@MDAndersonNews
@SITCancer
@IBCG_BladderCA
@IBCN1997
@KKBree
@pjhensley11
@bcan_chisolm
2
26
72
Dear urology colleagues: I need your support. Lone urologist going up against 3 medical oncologists at
#GU19
. I smell a set up on
#ValentinesDay
@apolo_andrea
@ArjunBalarMD
🧡THURSDAY 2/14 DINNER🧡 Nothing says ❤️ like watching your favorite GU oncs & uros breaking down the 🔥 topics in
#BladderCancer
debate-style!
@B_C_A_N
receives a donation for each attendee; walk-ins welcome!
@UroDocAsh
#GU19
#ThereWillBeChocolate
1
6
15
8
3
71
@JoCresswell4
@BAUSurology
@AlisonBirtle
@lydiamakaroff
Our bladder cancer patients need the *right* kind of attention with a superb TURBT
@bbmdmsk
Mismanaged/misdiagnosed bladder cancer kills log times faster than undersampled prostate cancer
@ahmostafid
@MRoupret
#EAU22
5
24
71
So true! “90% of published data is insufficient to change clinical practice”
@NDowJames
@USANZUrology
#USANZ19
1
25
71
Looking forward to seeing you all at
#AUA22
@AmerUrological
@IBCG_BladderCA
@SimaPorten
@SWilliams_MD
@shilpaonc
@garysteinbergmd
@joanfundi
@pcvblack
@angiesmith_uro
@UrogerliMD
@pjhensley11
@AStenzl
@MattGalsky
@spsutkaMD
@WesKassouf
@tbivala1
3
18
70
TURBT remains the most critical first step in management of
#BladderCancer
patients
Herein we highlight some ways to optimize outcomes
@ahmostafid
@MarekBabjuk
@joanfundi
@siadaneshmand
@JimCatto
@EurUrolOncol
@urotoday
@angiesmith_uro
@BladderCancerUS
#MedTwitter
@EurUrolOncol
Current Highlight: Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours
@ahmostafid
1
26
52
2
19
69
The evidence for role of neoadjuvant therapy in NMIBC continues to mount
2 doses of NAC with MMC reduced risk of recurrence by 63%:
@JUrology
Intensive MMC – 3/wk x 2 wks – reduced need for TURBT in 57% patients
#BladderCancer
7
28
71
Let this sink in: the estimated monetary value of the time US-based reviewers spent on peer reviews was over 1.5 billion dollars in 2020
H/T
@nnavai
6
23
67
Patient and Carer Experiences with
#BladderCancer
:
Results from this Global Survey identifies clear areas for improvement. We hope these findings will provide an evidence base to guide future initiatives that address the unmet needs of patients and their carers.
3
20
69